Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19 | Reuters
Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19 | Reuters A source with the Drug Controller General of India said the pill has not shown "significant efficacy" against moderate COVID-19, though it was having success against mild cases.